Department of Pharmacology, Vanderbilt University, Nashville, TN, United States of America.
Department of Biochemistry, Vanderbilt University, Nashville, TN, United States of America.
PLoS One. 2019 Apr 10;14(4):e0215140. doi: 10.1371/journal.pone.0215140. eCollection 2019.
Lyn kinase (Lck/Yes related novel protein tyrosine kinase) belongs to the family of Src-related non-receptor tyrosine kinases. Consistent with physiological roles in cell growth and proliferation, aberrant function of Lyn is associated with various forms of cancer, including leukemia, breast cancer and melanoma. Here, we determine a 1.3 Å resolution crystal structure of the polyproline-binding SH3 regulatory domain of human Lyn kinase, which adopts a five-stranded β-barrel fold. Mapping of cancer-associated point mutations onto this structure reveals that these amino acid substitutions are distributed throughout the SH3 domain and may affect Lyn kinase function distinctly.
Lyn 激酶(Lck/Yes 相关新型蛋白酪氨酸激酶)属于Src 相关非受体酪氨酸激酶家族。与细胞生长和增殖的生理作用一致,Lyn 的异常功能与各种形式的癌症有关,包括白血病、乳腺癌和黑色素瘤。在这里,我们确定了人 Lyn 激酶的多脯氨酸结合 SH3 调节结构域的 1.3Å 分辨率晶体结构,其采用五股β-桶折叠。将癌症相关点突变映射到该结构上表明,这些氨基酸取代分布在整个 SH3 结构域中,并且可能以不同的方式影响 Lyn 激酶的功能。